The Economics of Multiple Myeloma Treatment: Market Impact and Cost Challenges
Share this Post to earn Money ( Upto ₹100 per 1000 Views )

Multiple myeloma is a complex blood cancer that arises from the proliferation of monoclonal plasma cells within the bone marrow. These rogue cells produce excessive paraproteins, causing damage to bones, kidneys, and the immune system. Although a cure remains elusive, enhanced understanding of disease mechanisms has led to transformative changes in treatment strategies.